Notably, the serum Aβ42/Aβ40 and p-tau-181/Aβ42 ratios are recognized as stronger factors than the levels of Aβ or tau alone and correlate strongly with brain atrophy and disease progression [87,88]. This evidence concerns the gene MAPT and Brain atrophy.